Skip to content

CapEx at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.05B+31.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$230.6M+0.6%
Glaukos logo
GlaukosGKOS
$3.96M+104%
AbbVie logo
AbbVieABBV
$265M+12.8%
Bausch + Lomb logo
Bausch + LombBLCO
$100M-9.1%
HRO
HarrowHROW
$194K+14.1%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's capex?
Schering-Plough (SGP) reported capex of $676K in Q1 2026.
How has Schering-Plough's capex changed year-over-year?
Schering-Plough's capex increased by 312.2% year-over-year, from $164K to $676K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.